Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
4.000
-0.320 (-7.41%)
At close: Oct 9, 2026, 4:00 PM EDT
3.400
-0.600 (-15.00%)
After-hours: Oct 9, 2026, 7:43 PM EDT
Niki BioSolutions Market Cap
Niki BioSolutions has a market cap or net worth of $11.75 million as of October 9, 2026. It is the 40,725th most valuable company in the world and the 5,557th biggest in the United States. Its market cap has decreased by 31.73% in one year.
Market Cap
11.75M
Enterprise Value
13.43M
1-Year Change
-31.73%
Global Rank
Country Rank
#5,557 United States
Category
ChartMarket Cap Chart
Since December 18, 2018, Niki BioSolutions's market cap has decreased from $415.79M to $11.75M, a decrease of -97.17%. That is a compound annual growth rate of -36.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 11.75M | 36.17% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Citius Pharmaceuticals | 13.36M |
| Cerenome | 13.28M |
| Cellectar Biosciences | 13.14M |
| Tempest Therapeutics | 12.68M |
| Pluri | 12.34M |
| Intensity Therapeutics | 12.08M |
| BioLineRx | 11.81M |
| Passage Bio | 11.71M |